BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 21539811)

  • 1. Nek6 suppresses the premature senescence of human cancer cells induced by camptothecin and doxorubicin treatment.
    Jee HJ; Kim HJ; Kim AJ; Song N; Kim M; Yun J
    Biochem Biophys Res Commun; 2011 May; 408(4):669-73. PubMed ID: 21539811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The inhibition of Nek6 function sensitizes human cancer cells to premature senescence upon serum reduction or anticancer drug treatment.
    Jee HJ; Kim HJ; Kim AJ; Song N; Kim M; Lee HJ; Yun J
    Cancer Lett; 2013 Jul; 335(1):175-82. PubMed ID: 23416273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nek6 overexpression antagonizes p53-induced senescence in human cancer cells.
    Jee HJ; Kim AJ; Song N; Kim HJ; Kim M; Koh H; Yun J
    Cell Cycle; 2010 Dec; 9(23):4703-10. PubMed ID: 21099361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melatonin suppresses doxorubicin-induced premature senescence of A549 lung cancer cells by ameliorating mitochondrial dysfunction.
    Song N; Kim AJ; Kim HJ; Jee HJ; Kim M; Yoo YH; Yun J
    J Pineal Res; 2012 Nov; 53(4):335-43. PubMed ID: 22536785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nek6 mediates human cancer cell transformation and is a potential cancer therapeutic target.
    Nassirpour R; Shao L; Flanagan P; Abrams T; Jallal B; Smeal T; Yin MJ
    Mol Cancer Res; 2010 May; 8(5):717-28. PubMed ID: 20407017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evasion of a single-step, chemotherapy-induced senescence in breast cancer cells: implications for treatment response.
    Elmore LW; Di X; Dumur C; Holt SE; Gewirtz DA
    Clin Cancer Res; 2005 Apr; 11(7):2637-43. PubMed ID: 15814644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autophagy inhibition switches low-dose camptothecin-induced premature senescence to apoptosis in human colorectal cancer cells.
    Zhang JW; Zhang SS; Song JR; Sun K; Zong C; Zhao QD; Liu WT; Li R; Wu MC; Wei LX
    Biochem Pharmacol; 2014 Aug; 90(3):265-75. PubMed ID: 24858802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of premature senescence in cardiomyocytes by doxorubicin as a novel mechanism of myocardial damage.
    Maejima Y; Adachi S; Ito H; Hirao K; Isobe M
    Aging Cell; 2008 Mar; 7(2):125-36. PubMed ID: 18031568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HMGB1 modulates the balance between senescence and apoptosis in response to genotoxic stress.
    Lee JJ; Park IH; Rhee WJ; Kim HS; Shin JS
    FASEB J; 2019 Oct; 33(10):10942-10953. PubMed ID: 31284735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of p53 and p21waf1/cip1 in senescence-like terminal proliferation arrest induced in human tumor cells by chemotherapeutic drugs.
    Chang BD; Xuan Y; Broude EV; Zhu H; Schott B; Fang J; Roninson IB
    Oncogene; 1999 Aug; 18(34):4808-18. PubMed ID: 10490814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNMT3a plays a role in switches between doxorubicin-induced senescence and apoptosis of colorectal cancer cells.
    Zhang Y; Gao Y; Zhang G; Huang S; Dong Z; Kong C; Su D; Du J; Zhu S; Liang Q; Zhang J; Lu J; Huang B
    Int J Cancer; 2011 Feb; 128(3):551-61. PubMed ID: 20473858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Escape from therapy-induced accelerated cellular senescence in p53-null lung cancer cells and in human lung cancers.
    Roberson RS; Kussick SJ; Vallieres E; Chen SY; Wu DY
    Cancer Res; 2005 Apr; 65(7):2795-803. PubMed ID: 15805280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roscovitine modulates DNA repair and senescence: implications for combination chemotherapy.
    Crescenzi E; Palumbo G; Brady HJ
    Clin Cancer Res; 2005 Nov; 11(22):8158-71. PubMed ID: 16299248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MLN8054, an inhibitor of Aurora A kinase, induces senescence in human tumor cells both in vitro and in vivo.
    Huck JJ; Zhang M; McDonald A; Bowman D; Hoar KM; Stringer B; Ecsedy J; Manfredi MG; Hyer ML
    Mol Cancer Res; 2010 Mar; 8(3):373-84. PubMed ID: 20197380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An inhibitory role of NEK6 in TGFβ/Smad signaling pathway.
    Zuo J; Ma H; Cai H; Wu Y; Jiang W; Yu L
    BMB Rep; 2015 Aug; 48(8):473-8. PubMed ID: 25523445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NIMA-related kinase-6 (NEK6) as an executable target in cancer.
    Panchal NK; Mohanty S; Prince SE
    Clin Transl Oncol; 2023 Jan; 25(1):66-77. PubMed ID: 36074296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential control of the NIMA-related kinases, Nek6 and Nek7, by serum stimulation.
    Minoguchi S; Minoguchi M; Yoshimura A
    Biochem Biophys Res Commun; 2003 Feb; 301(4):899-906. PubMed ID: 12589797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Additive effects of C(2)-ceramide on paclitaxel-induced premature senescence of human lung cancer cells.
    Chen JY; Hwang CC; Chen WY; Lee JC; Fu TF; Fang K; Chu YC; Huang YL; Lin JC; Tsai WH; Chang HW; Chen BH; Chiu CC
    Life Sci; 2010 Sep; 87(11-12):350-7. PubMed ID: 20624405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of NIMA-related kinase 6 (NEK6) contributes to malignant growth and dismal prognosis in Human Breast Cancer.
    He Z; Ni X; Xia L; Shao Z
    Pathol Res Pract; 2018 Oct; 214(10):1648-1654. PubMed ID: 30153958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Permanent cell cycle arrest in asynchronously proliferating normal human fibroblasts treated with doxorubicin or etoposide but not camptothecin.
    Robles SJ; Buehler PW; Negrusz A; Adami GR
    Biochem Pharmacol; 1999 Aug; 58(4):675-85. PubMed ID: 10413306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.